Cargando…
Pleiotropic Effects of Ticagrelor: Influence on CYP4F2 Gene and Protein Expression in HUVEC and HepG2, and Escherichia coli Bacterial Survival
BACKGROUND: Antiplatelet drugs, such as ticagrelor, which target platelet P2Y(12) receptors, are used for prevention of ischemic heart disease. Ticagrelor is also known to have pleiotropic effects of unknown mechanisms. Ticagrelor could influence the expression of molecules involved in resolution of...
Autores principales: | Meskauskaite, Ugne, Andruskeviciute, Silvija, Ciapiene, Ieva, Giedraitiene, Agne, Lesauskaite, Vaiva, Tatarunas, Vacis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359174/ https://www.ncbi.nlm.nih.gov/pubmed/35959420 http://dx.doi.org/10.2147/DDDT.S357985 |
Ejemplares similares
-
Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome
por: Tatarunas, Vacis, et al.
Publicado: (2020) -
The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction
por: Parpugga, Tajinder Kumar, et al.
Publicado: (2015) -
SARS-CoV-2 Infection, Sex-Related Differences, and a Possible Personalized Treatment Approach with Valproic Acid: A Review
por: Stakišaitis, Donatas, et al.
Publicado: (2022) -
Assessment of Absorption of Glycated Nail Proteins in Patients with Diabetes Mellitus and Diabetic Retinopathy
por: Jurgeleviciene, Ieva, et al.
Publicado: (2020) -
Retinal and Choroidal Thinning—A Predictor of Coronary Artery Occlusion?
por: Matulevičiūtė, Indrė, et al.
Publicado: (2022)